Rhein Biotech NV

Rhein Biotech is a biotechnology group, developing, manufacturing, marketing and licensing-out valuable and affordable products for prevention and treatment of mass diseases.
Mission: To be a leading biotech company belonging to the European top 5.
Technology: Rhein Biotech owns a broad portfolio of technologies for the most efficient production of recombinant proteins such as vaccines, therapeutics and enzymes.
Products: Rhein Biotech develops new and improved biotechnology products and is commercializing these products and technologies through partnering and licensing out. Market: The Rhein Biotech group targets the following markets: Vaccines like Hepatitis B and C, Cytokines with Immune Modulators like Interferons and InterleUKins

Activity:

- Licensing & Business Development
- Manufacturing
- Research & Development

Product / Technology type(s) covered:

- Bio
- Enzymes
- Pharmaceuticals / Therapeutics
- Preventive
- Proteins
- Technology

Therapeutic targets:

Markets Covered

a. HeadQuarter: Netherlands

b. Continent(s) active: Europe , Asia , South America

c. Countries active: Subsidiaries in Germany, Korea and Argentina and a global network of licensees

Corporate data:

Number of Employees: >400

Turnover:

Amount:	Year:	Currency:
82300000	2001	Euro

Year founded: